Evidence map›Paper›PMID 36568835›Full record

SynthesisThe Yale journal of biology and medicine2022

Global status of Azithromycin and Erythromycin Resistance Rates in

Zhiwei Lu, Danyal Abbasi Tadi, Jinchao Fu, Khalil Azizian, Ebrahim Kouhsari

Open access · greenAbstract readMeta-AnalysisSystematic Review
PubMed Full text at PMC
In one paragraph

Synthesis in The Yale journal of biology and medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Pooled it
  2. Gallic acid synergistically enhances the antibacterial activity of azithromycin in MRSA.International microbiology : the official journal of the Spanish Society for Microbiology · 2025
    Article
  3. Article
  4. Article
  5. Non-typhoidalJAC-antimicrobial resistance · 2024
    Review
  6. Primed for Discovery.Biochemistry · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Zhiwei LuGraduate School, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.
Danyal Abbasi TadiDepartment of Veterinary, Azad University of Shahr-e Kord, Shahr-e Kord, Iran.
Jinchao FuDepartment of General Practice, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, Zhejiang, China.
Khalil AzizianDepartment of Microbiology, Faculty of Medicine, Kurdistan University of Medical Sciences, Sanandaj, Iran.
Ebrahim KouhsariLaboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan, Iran.
Golestan University · IRKurdistan University of Medical Sciences · IRZhejiang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AzithromycinGonorrheaAnti-Bacterial AgentsDrug Resistance, BacterialErythromycinHumansMicrobial Sensitivity TestsNeisseria gonorrhoeaeAnti-Bacterial AgentsAzithromycinErythromycinAnimicrobial Resistanceantibiotic resistanceazithromycinerythromycinNeisseria gonorrhoeaesystematic review and meta-analysis

Identifiers

PMID36568835
PMCPMC9765340
OpenAlexW4312211348

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.